adjuvant chemotherapy
Assessment of the relation between the expression of oxaliplatin transporters in colorectal cancer and response to FOLFOX-4 adjuvant chemotherapy: A case control study
... by adjuvant chemotherapy [ 1 , 2 ]. First-line chemotherapy commonly associates 5-fluorouracil, folinic acid and oxaliplatin in the FOLFOX-4 ...receiving adjuvant treatment do not benefit from ...
13
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2–14)
... generation prognostic tests (OncotypeDX ™, Mammaprint®) are now used worldwide to guide decision making regarding adjuvant chemotherapy. These tests were validated initially based on sub- stantial ...
9
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial.
... with adjuvant anthracycline-based ...to chemotherapy. In the neo-adjuvant setting, correla- tion between Ki67 positivity and response to taxanes, either as monotherapy [37] or in association with ...
15
Preoperative Hyperfractionated Accelerated Radiotherapy (HART) with concomittant CPT-11 immediately followed by surgery and adjuvant chemotherapy. A phase I study (Trial 98-02)
... Preoperative Hyperfractionated Accelerated Radiotherapy (HART) with concomittant CPT-11 immediately followed by surgery and adjuvant chemotherapy. A phase I study (Trial 98-02) P. A. Coucke 1 , V. Volter 2 ...
1
Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002.
... (ECF) chemotherapy) with a strategy of primary surgery followed by adjuvant ECF chemotherapy (6 cycles) in patients with a SRC tumour and eligible for curative ...by adjuvant ...
10
Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis
... of adjuvant chemotherapy (ADJ) in this context has scarcely been ...administrating adjuvant chemotherapy in a real life cohort of BC patients with invasive residual disease after ...additional ...
16
ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
... The first study evaluating the value of XRCC1-399 as a pharmacogenetic marker was per- formed in 61 patients with advanced CRC receiving 5FU/oxaliplatin chemotherapy (8). The authors showed that 73% (8/11) of ...
9
Prospective study of the energy balance disruption during adjuvant chemotherapy in post-menopausal early-stage breast cancer patient
... The global cancer burden is becoming a major threat to many countries. It has been observed in studies mainly carried out in developed countries that the understanding of cancer has improved; And today we have a better ...
54
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
... overexpression in PDAC cell lines with GATA6 ChIP-Seq and RNA-Seq data, in order to understand the mechanism of GATA6 functions. We then con firmed some of our observations in primary patient samples, some of which were ...
13
Incomplete copolymer degradation of in situ chemotherapy
... fractionated focal irradiation at a dose of 2 Gy per fraction given once daily 5 days per week over a period of 6 weeks, for a total dose of 59.4 Gy focal radiotherapy and 13 regimens of temozolomide at a dose of 75 mg ...
11
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial)
... offer adjuvant chemotherapy are assisted by identifying patients at greater risk of recur- ...with adjuvant endocrine therapy (ET) [ 5 , 7 ...received adjuvant chemoendocrine therapy [ 10 – 12 ...
10
Relation between polymorphisms and chemotherapy in lung cancer
... surgery, adjuvant chemotherapy and radiation therapy, hormonal therapy and survival (relapse, follow up, death) of men who were referred to our centre with breast ...
2
Chemotherapy in resected neuroendocrine carcinomas of the digestive
... adjuvant chemotherapy, in patients operated for a localised NEC of the digestive tract.. 1019[r] ...
18
Screening anti-colorectal cancer drugs: free radical chemotherapy
... Given the successful anti-tumorigenic model as described by eq 1 and 2 for wide range of anticancer drugs, the screening model used was to calculate five molecular parameters for the p[r] ...
14
Adjuvant MIBGI131 therapy in a young patients with aggressive paraganglioma
... scintigraphy showed total tumour resection. To date, no recurrence was found and the patient did not show hematopoietic adverse effects. DISCUSSION Malignant paragangliomas has a 5-year survival rates up to 50%. ...
1
CardioPulse: cardiac imaging of adult cancer patients on chemotherapy.
... Now, a large study of nearly 15 000 men and women, recently published in the European Heart Journal, 1 shows that drinking up to seven drinks a week in early to middle age is associated [r] ...
6
Nouvelles approches vaccinales contre le rotavirus humain et effet adjuvant de la flagelline
... plantes et administrés par voie orale ce qui a permis de conférer une protection partielle contre le rotavirus dans des modèles d'infection chez la souris. Même si ces tr[r] ...
272
Chemotherapy-driven dysbiosis in the intestinal microbiome
... partitioned into a training set (including 90% of the patients) and a validation set (including the remaining 10%). The random forest classi fier was trained on the 90% and used to predict the outcome of the held out 10%. ...
14
Impact du bevacizumab adjuvant sur les lymphocèles dans les tumeurs épithéliales malignes de l’ovaire de stade avancé
... bevacizumab adjuvant sur la lymphocèle symptomatique chez des patientes atteintes d’un cancer de l’ovaire de stade avancé ayant eu une chirurgie ...bevacizumab adjuvant, soit 24,5% des ...bevacizumab ...
84
View of Chemotherapy Induced Cardiotoxicity: Facts, Breakthroughs, and Challenges.
... AGENTS Chemotherapy-induced cardiotoxicity is a serious clinical prob- lem faced by both cardiologists and oncologists (Table ...that chemotherapy might worsen an underlying cardiac problem or create a new ...
6